Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis
Alejandro Balsa; Petra Díaz del Campo Fontecha; Lucía Silva Fernández; José Valencia Martín; Virginia Nistal Martínez; Fernando León Vázquez; M. Vanesa Hernández Hernández; Héctor Corominas; Rafael Cáliz Cáliz; José María Aguado García; Gloria Candelas Rodríguez; Nora Ibargoyen Roteta; Arturo Martí Carvajal; M. Nieves Plana Farras; Janet Puñal Riobóo; Hye Sang Park; Yolanda Triñanes Pego; Virginia Villaverde García;
Reumatol Clin. 2023;19:533-48
Right ventriculoarterial coupling as a marker of subclinical myocardial damage in rheumatoid arthritis
Tomás Miranda-Aquino; Diego Alejandro Ramos-Aguas; Silvia Esmeralda Pérez-Topete; María del Socorro Cepeda-Rocha; Xochitl Citlalli Gómez-Gómez; Daniel Ochoa-Castillo; Sergio Cerpa-Cruz; Verónica González-Díaz; Christian González-Padilla; Jorge Eduardo Hernández-del Río;
10.1016/j.reumae.2025.501841
Comorbidities in Mexican Mestizo patients with rheumatoid arthritis: A cross-sectional study of 523 patients in a preventive cardio-rheumatology clinic
Rosa I. Arvizu-Rivera; Jesus A. Cardenas-de la Garza; Valeria Gonzalez-Gonzalez; Dionicio A. Galarza-Delgado; Jose R. Azpiri-Lopez; Andrea L. Guajardo-Aldaco; Maria F. Elizondo-Benitez; Iris J. Colunga-Pedraza;
Reumatol Clin. 2025;21: